MarketCap
Facebook
X
Telegram
OpGen Operating Cycle | OPGN
Annual Operating Cycle OpGen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.68 | 4.66 | 249 | 578 | 570 | 197 | 428 | 154 | 183 | 160 | 273 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 578 | 1.68 | 254 |
Quarterly Operating Cycle OpGen
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 46.5 | - | - | - | - | - | - | 522 | 526 | 620 | - | 338 | 718 | 1.63 K | - | 655 | 819 | 441 | - | 56.4 | 50.1 | 90.3 | - | 79.9 | 51.3 | 42.1 | - | 61.8 | 43.2 | 63.8 | - | 99.1 | 105 | 79.9 | - | 65.2 | 41.9 | 51.8 | - | 63.1 | 165 | 114 | - | 55.1 | 42.9 | 21 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.63 K | 21 | 250 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K |  USA |
 |
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B |  Niderland |
 |
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Charles River Laboratories International
CRL
|
65 | $ 280.05 | 0.13 % | $ 13.9 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 234.4 | 0.08 % | $ 26 B | USA |
 |
Biomerica
BMRA
|
204 | $ 1.58 | 3.18 % | $ 3.63 M | USA |
 |
DarioHealth Corp.
DRIO
|
227 | $ 7.59 | 3.48 % | $ 30.2 M |  Israel |
 |
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
1.79 K | $ 1.4 | 0.68 % | $ 1.86 M | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
DexCom
DXCM
|
202 | $ 89.75 | 0.75 % | $ 35 B | USA |
 |
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | USA |
 |
Interpace Biosciences
IDXG
|
96 | $ 1.66 | 0.6 % | $ 7.34 M | USA |
 |
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | USA |
 |
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | China |
 |
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | USA |
 |
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | USA |
 |
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | USA |
 |
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | USA |
 |
Soleno Therapeutics
SLNO
|
1.04 K | - | - | $ 2.69 B | USA |
 |
Psychemedics Corporation
PMD
|
57.4 | - | -1.84 % | $ 15.3 M | USA |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
63.4 | $ 163.15 | 0.19 % | $ 12.8 B |  Irlanda |
 |
Syneos Health
SYNH
|
32.3 | - | - | $ 4.46 B | USA |
 |
Invitae Corporation
NVTA
|
368 | - | - | $ 21.2 M | USA |
 |
Organovo Holdings
ONVO
|
86.4 | - | -2.3 % | $ 19.4 M | USA |
 |
IQVIA Holdings
IQV
|
73.9 | $ 236.66 | 0.28 % | $ 40.7 B | USA |
 |
T2 Biosystems
TTOO
|
91.3 | - | -39.35 % | $ 313 K | USA |
 |
Anixa Biosciences
ANIX
|
385 | $ 3.18 | 0.93 % | $ 103 K | USA |
 |
PerkinElmer
PKI
|
92.2 | - | -0.91 % | $ 14.7 B | USA |
 |
Meridian Bioscience
VIVO
|
238 | - | - | $ 1.49 B | USA |
 |
ENDRA Life Sciences
NDRA
|
412 | $ 4.47 | 1.36 % | $ 3.52 M | USA |
 |
Quotient Limited
QTNT
|
396 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Renalytix AI plc
RNLX
|
15.9 | - | 5.66 % | $ 22.7 M |  Britain |
 |
Natera
NTRA
|
48.3 | $ 309.93 | 1.04 % | $ 42.4 B | USA |
 |
Myriad Genetics
MYGN
|
95.1 | $ 3.03 | 0.62 % | $ 281 M | USA |
 |
NeoGenomics
NEO
|
102 | $ 15.94 | 0.24 % | $ 2.04 B | USA |
 |
National Research Corporation
NRC
|
29.4 | $ 21.19 | 0.84 % | $ 474 M | USA |
 |
Surmodics
SRDX
|
201 | - | - | $ 608 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 27.29 | 0.51 % | $ 25.9 B | Niderland |
 |
Quidel Corporation
QDEL
|
68.4 | $ 14.3 | 1.75 % | $ 602 M | USA |